{'fraction_non_alphanumeric': 0.034013605442176874, 'fraction_numerical': 0.031746031746031744, 'mean_word_length': 5.174825174825175, 'pattern_counts': {'":': 0, '<': 1, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Prenatal Fish Oil Supplementation and Allergy: 6-Year Follow-up of a Randomized Controlled Trial

KP Best, T Sullivan, D Palmer. Pediatrics. 2016;137(6):e20154443

To assess whether prenatal supplementation with ω-3 (n-3) long-chain polyunsaturated fatty acids (LCPUFA) exerts a protective effect on the development of immunoglobulin E–mediated allergic conditions at 6 years of age in a prospective birth cohort.

A total of 706 children with a family history of allergic disease were enrolled into this study as part of the Docosahexaenoic Acid to Optimize Mother Infant Outcome trial.

Women with a singleton pregnancy (<21 weeks’ gestation) were recruited from the Docosahexaenoic Acid to Optimize Mother Infant Outcome randomized controlled trial (RCT) during an antenatal clinic visit. Participants were randomly assigned in a double-blind manner to receive either 500 mg of …